JACKSONVILLE, Fla.--(BUSINESS WIRE)--NovaBone Osteobiologics Worldwide, LLC (NBOW) announced the introduction of NovaBone Porous Morsels to its portfolio of biologically active bone graft substitutes. The new formulation provides users with a graft that signals and recruits bone forming cells while providing a matrix of open, interconnected pores for bone growth to occur.
